RE-BVS – Piemonte Repository

Sfoglia per AUTORE
SCHEINER B
Collezione AOU Novara

Items : 3

Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumours. in Journal of hepatology / J Hepatol. 2024 Mar;80(3):431-442. doi: 10.1016/j.jhep.2023.10.040. Epub 2023 Nov 15.

2024
AOU Novara

Celsa C; Cabibbo G; Fulgenzi CAM; Scheiner B; D'Alessio A; Manfredi GF; Nishida N; Ang C; Marron TU; Saeed A; Wietharn B; Pinter M; Cheon J; Huang YH; Lee PC; Phen S; Gampa A; Pillai A; Vivaldi C; Salani F; Masi G; Roehlen N; Thimme R; Vogel A; Schönlein M; von Felden J; Schulze K; Wege H; Galle PR; et alii...

Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab-bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study. in The Lancet. Oncology / Lancet Oncol. 2023 Dec;24(12):1411-1422. doi: 10.1016/S1470-2045(23)00468-0. Epub 2023 Nov 8.

2023
AOU Novara

Zeng Q; Klein C; Caruso S; Maille P; Allende DS; Mínguez B; Iavarone M; Ningarhari M; Casadei-Gardini A; Pedica F; Rimini M; Perbellini R; Boulagnon-Rombi C; Heurgué A; Maggioni M; Rela M; Vij M; Baulande S; Legoix P; Lameiras S; Bruges L; Gnemmi V; Nault JC; Campani C; Rhee H; Park YN; Iñarrairaegui M; Garcia-Porrero G; Argemi J; et alii...

Mechanisms of Resistance to Immunotherapy in Hepatocellular Carcinoma. in Journal of hepatocellular carcinoma / J Hepatocell Carcinoma. 2023 Nov 3;10:1955-1971. doi: 10.2147/JHC.S291553. eCollection 2023.

2023
AOU Novara

Donadon M; Rigamonti C; Burlone M; Vincenzi F; Minisini R; Pirisi M; Mauri FA; Gennari A; Pinter M; Korolewicz J; Fulgenzi CAM; Scheiner B; Acuti N; Jones C; John C; Celsa C; Manfredi GF; Cabibbo G; D'Alessio A; Pinato DJ;